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Background: It has been suggested that antioxidant
deficiency may play a role in the pathogenesis of
chronic pancreatitis. The aim of this review was to
analyse the evidence for this relationship and to
consider the role of antioxidant supplementation in
the treatment of chronic pancreatitis.
Methods: Medline review of all English language
publications for the years 1966-1998.
Results and Conclusions: There is evidence that
patients with chronic pancreatitis have enhanced
levels of free radical production, cytochrome P450
induction and antioxidant deficiencies, in particular
selenium. The limited published literature in this
field suggests that dietary antioxidant supplementa-
tion may ameliorate the pain associated with chronic
pancreatitis, diminish the frequency of acute exacer-
bations and reduce the requirement for pancreatic
surgery. These findings await confirmation by a large
prospective placebo-controlled study.
Keywords: Chronic pancreatitis, selenium, antioxidant, defi-
ciency, replacement therapy
INTRODUCTION
Selenium was first identified in 1817 by the
Swedish scientist J6ns Jacob Berzelius as a red
deposit on the walls of a lead chamber used in
the production of sulphuric acid [1]. It derives
its name from the Greek moon goddess Selene
and in its chemical properties, it shares many
similarities with sulphur [1]. It is a ubiquitous
element and is widely distributed in the earth’s
crust, in the environment and the food chain.
It occurs naturally in an inorganic state as sele-
nite and selenate, and in an organic, state as
selenoamino acids [1,2]. The latter are present
particularly in plants and constitute the principal
source of dietary selenium [3]. The selenium
content of plants is directly related to the amount
of the element present within the soil in which
the plants grow. This in turn is inversely related
to the annual rainfall of the locality, as selenium
is leached out of soil by virtue of its aqueous
solubility [4]. There is a wide geographic varia-
tion in the amount of selenium in soil, with low
levels found in Denmark, Finland, New Zealand,
Australia, Siberia, Korea and certain parts of
north-eastern and south central China. Regions
with a high soil selenium content include parts
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of Western China and several western states of
the United States of America [1, 4].
This review examines the role of selenium in
the pathogenesis of chronic pancreatitis and its
potential role in the treatment of this condition.
It is based upon literature obtained from a
Medline search covering the period 1966 to 1998
which identified all English language publica-
tions using the keywords selenium, antioxidant
deficiency and chronic pancreatitis.
SELENIUM PHYSIOLOGY
In food, selenium is usually present in the form
of organic compounds such as selenomethio-
nine, selenocysteine and selenotaurine. Foods
with the highest selenium content are brazil nuts
(254 g/100 g) and crab meat (84 g/100 g). The
levels in vegetables and dairy products are
much lower (<2tg/100g) [5-7]. Selenium, in
the form of selenite, selenate, selenocysteine and
selenomethionine is absorbed in the duodenum.
There is considerable variation in the absorption
of selenium compounds from around 55% for
selenite to 90% for selenomethionine. Absorp-
tion is inhibited by methionine, heavy metals
(cadmium, arsenic, mercury) and food rich in
fibre, while it is promoted by vitamins A, C and
E [5]. In blood, absorbed selenium is rapidly
taken up by red blood cells where it is reduced
by thiols to hydrogen selenide, released into the
plasma and transported bound to alpha and beta
globulins [5]. Selenium occurs in all human
tissue, in particular the liver (0.63tg/g) and
kidney (0.39 g/g) [2].
DIETARY SELENIUM
Based upon a series of depletion-repletion
studies carried out in Chinese males the United
States set the recommended daily intakes for
selenium at 70tg/day for men and 55 g/day
for women [8,9]. Recommended daily intakes
for other groups were extrapolated from the
adult range on the basis of body weight, with a
factor added for growth. The United Kingdom
Department of Health has recommended daily
selenium intakes of 1.0tg/kg based upon the
depletion-repletion studies and the amount of
selenium required to maintain glutathione per-
oxidase at its plateau of activity [10].
Based upon dietary estimates Thorn et al. [7]
found in 1978 that the intake of selenium by the
United Kingdom population was adequate. A
more recent study by the Ministry of Agricul-
ture, Fisheries and Food [6, 11] has reported an
average intake of only 34 tg/day, approximately
50% of the recommended daily intake. This
decline in dietary selenium intake has resulted
from a reduction in imports of selenium-rich
wheat from North America following the United
Kingdom’s entry into the European Union and
also as a result of changes in breadmaking
technology.
SELENOPROTEINS
The biochemical function of selenium was
unknown until 1973, when it was discovered
that it was an integral component of the active
site of the mammalian enzyme glutathione
peroxidase [12]. It is now well established that
selenium is a highly specific component of
enzymes in both eukaryotes and prokaryotes.
The selenium-dependent enzymes are redox
catalysts and most contain selenium in the form
of selenocysteine residues [4]. Eukaryotic sele-
noenzymes identified include the glutathione
peroxidases, tetraiodothyronine 5-deiodinase,
selenoprotein P, sperm capsule selenoprotein
and selenoprotein W [4,13,14].
The most important mammalian selenopro-
teins are the glutathione peroxidases. These
enzymes, together with superoxide dismutase
and catalase form part of the cellular defence
mechanism against reactive molecules and freeSELENIUM AND CHRONIC PANCREATITIS 209
radicals which cause lipid peroxidation and
interact with intra-cellular macromolecules
[4, 13-15]. The toxic oxygen derivatives, which
are neutralised by the antioxidants are produced
by normal cellular metabolic activity and by a
variety of injurious agents, including drugs,
toxins, and irradiation. In conjunction with
vitamins A, C and E, glutathione peroxidase
functions as a cellular protector against oxida-
tive damage, by. catalysing the breakdown of
hydrogen peroxide and fatty acyl lipid perox-
ides, in the presence of reduced glutathione, to
water and the corresponding alcohols. Such
peroxides are a source of potentially damaging
free radicals which can cause peroxidation of
polyunsaturated fatty acids in the cell mem-
brane [4, 13, 14].
It is postulated that deficiencies of micronu-
trients such as selenium reduce the ability of
these antioxidant free radical scavenging en-
zymes leading to a situation referred to as oxi-
dative stress [16].
ENDEMIC SELENIUM DEFICIENCY
AND HUMAN DISEASE
The evidence for the effects of selenium defi-
ciency in humans come from indirect evidence
from China and from findings in patients
receiving total parenteral nutrition [1]. Two
diseases found in areas of low-selenium content
soil in China have been ascribed to selenium
defeciency. ’Keshan disease is a cardiomyopathy
seen commonly in childhood characterised by
multifocal necrosis and fibrous replacement of
the myocardium. Several large-scale studies
have shown that prophylactic treatment of the
population with oral supplements have resulted
in virtual eradication of the condition in en-
demic areas. Kashin-Beck disease (osteoarthritis
deformans endemica) is another selenium-re-
sponsive endemic disease occurring in Northern
China, North Korea, and eastern Siberia. The
disease affects principally children and is char-
acterised by a chronic disabling degenerative
osteoarthritis [1]. It is interesting that there are
no reports so far of a high prevalence of chronic
pancreatitis in these Chinese patients. However,
in the Indian Subcontinent there are increasing
reports of a high prevalence of chronic pancrea-
titis [17,18]. Evidence of clinically significant
selenium deficiency from the developed world
is confined to case reports of patients receiving
parenteral nutrition, in whom symptoms re-
solved upon selenium supplementation. The
syndromes reported included myalgia and myo-
sitis; and cardiomyopathy. Following these early
observations selenium supplementation of par-
enteral nutrition has become routine practice [1].
CHRONIC PANCREATITIS
Chronic pancreatitis is defined as a persistent,
usually progressive, inflammatory condition
characterised by irregular sclerosis of the gland
with destruction and loss of exocrine parenchy-
ma [19]. It is less frequent than acute pancreatitis
and shows considerable geographical variation
in its incidence. In the United Kingdom the
annual incidence is in the order of 3 per 100,000
population, with 60-85% being alcohol-related
[19]. The condition affects males more frequently
and has its onset at a median age of 40 years. The
condition is seen more commonly in tropical
countries where protein malnutrition in infancy
is endemic. In these countries the disease affects
both genders with equal frequency and occurs in
patients below the age of 20 years [19].
OXIDATIVE STRESS
Oxidative stress refers to a situation that is
characterised by a relative deficiency in antiox-
idant levels compared to the rate of free radical
production and thus .it is a state of potential
tissue injury. The evidence that chronic pancrea-210 D.J. BOWREY et al.
titis is related to oxidative stress is indirect as
free radicals are undetectable in-vivo due to their
short half-life. There is a substantial body of
evidence showing antioxidant deficiency and
increased levels of free radical oxidation pro-
ducts in patients with chronic pancreatitis.
SELENIUM DEFICIENCYIN CHRONIC
PANCREATITIS
Initial evidence suggesting deficiencies of anti-
oxidants, in particular selenium, in chronic
pancreatitis was derived from the dietary ana-
lysis of index patients. Rose et al. [20] compared
the dietary histories of 15 patients with idio-
pathic chronic pancreatitis and found that index
patients had significantly reduced ingestion of
selenium; vitamins C and E; and riboflavin, than
did controls. Further, theophylline clearance
testing, employed as an index of cytochrome
P450 activity and by inference antioxidant
demand detected significant differences be-
tween patients with chronic pancreatitis and
controls. There was an inverse relationship
between theophylline clearance and selenium
intake, pancreatitics having a more rapid drug
clearance and lower selenium intake.
Subsequently, antioxidant deficiencies, in par-
ticular selenium were demonstrated by in-vivo
estimation of serum selenium from index pa-
tients. Mathew et al. [21] studied four groups of
patients: adults with hereditary pancreatitis
(n= 14), relatives of the adults with hereditary
pancreatitis (n 11), children with chronic pan-
creatitis (n--7) anda control population (n =65).
Controls had significantly higher serum sele-
nium and glutathione peroxidase levels com-
pared to each of the three other groups. Adults
with hereditary pancreatitis had significantly
reduced serum selenium levels compared to
their relatives (median 11.7 vs. 14.1 tg/dl), but
significantly greater selenium levels compared
to children with chronic pancreatitis (median
11.7 vs. 9.33 tg/dl). These observations suggest
that patients with hereditary pancreatitis may
have dietary deficiencies of antioxidants that
may compound an inherited predisposition to
this condition. Interestingly, the paediatric pa-
tients had the lowest selenium levels of any
group suggesting that the more severe the anti-
oxidant deficiency, the earlier the age at which
the condition becomes manifest.
Van Gossum etal. [22] found significantly
reduced levels of the following antioxidants:
selenium (median 54 vs. 87tg/1), vitamin A
(median 30 vs. 49tg/dl) and vitamin E (8 vs.
16 mg/1) in patients with alcohol-related chronic
pancreatitis (n=35) compared to healthy con-
trols (n= 14). Sub-group analysis revealed that
vitamin E levels were significantly lower in
patients with steatorrhoea compared to patients
in whom this feature was not observed. No
relationship between pancreatic exocrine func-
tion and selenium deficiency was seen, implying
that selenium deficiency was primary to the
pathophysiology of the condition, and not
secondary to pancreatic insufficiency.
Braganza et al. [23] studied 37 patients with
chronic pancreatitis (23 idiopathic, 14 alcohol-
related) and compared serum selenium levels to
41 controls. The mean selenium levels were
93 tg/1 (range 48-156) for the patient popula-
tion and 117tg/1 (range 81-161) for the control
population (p <0.001). For pancreatitics no dif-
ference was observed for selenium levels be-
tween patients with alcohol-related pancreatitis
and patients with idiopathic pancreatitis. How-
ever, when patients were classified according to
the presence or absence of pancreatic pain, the
subgroup of patients with pancreatic pain had
significantly lower selenium levels (mean 74 tg/
1) compared to patients in remission from pain
(mean level 107tg/1) and patients who had
never experienced pain (mean level 102 tg/1).
Tropical Pancreatitis
Several studies [17,18,24] have compared the
antioxidant profiles from chronic pancreatitics inSELENIUM AND CHRONIC PANCREATITIS 211
the United Kingdom (temperate-zone pancrea-
titis) and patients with chronic pancreatitics from
India and South Africa (tropical pancreatitis)
in an attempt to identify differences that might
explain the different demographics of the con-
dition in the two settings [19].
Explanations proposed to account for the
differences between sporadic chronic pancreati-
tis in the developed world and the endemic
calcific chronic pancreatitis occurring in the
tropics have centred upon the extent of antiox-
idant deficiencies. In a comparison of healthy
controls from Manchester, UK and Madras,
India, Braganza et al. [18] found that healthy
volunteers from India had significantly lower
levels of beta-carotene (medians 40 vs. 98 tg/1)
and ascorbic acid (medians 1.6 vs. 13mg/1)
compared with the British control population.
Levels of selenium (medians 117 vs. 119tg/1),
alpha-tocopherol (medians 4.8 vs. 4.7mmol/
mol.cholesterol) and vitamin C (medians 12 vs.
13mg/1) were similar in the two control
groups for both locations. At both sites
patients with chronic pancreatitis had signifi-
cantly lower levels of selenium, alpha-tocopher-
ol and vitamin C compared to controls derived
from the local population. Pancreatitics from
Manchester also showed reduced levels of beta-
carotene and ascorbic acid compared to local
controls.
Yadav et al. [17] studied controls and chronic
pancreatitis patients from Madras, India and
Manchester, United Kingdom and found that for
both locations chronic pancreatitics had reduced
serum levels of selenium compared to a control
population. Further, there was no difference in
the absolute selenium levels between equivalent
populations in the two locations despite a
significantly higher prevalence of diabetes in
the Indian patients. In a similar study comparing
the Manchester controls with controls from
Soweto, South Africa, Segal et al. [24] found
significantly reduced levels of vitamin C (med-
ians 3 vs. 13mg/1) and selenium (medians 105
vs. 119 tg/1) in the South African group. Levels
of beta-carotene and alpha-tocopherol were
comparable in the two populations.
It has been suggested that the differences in
the antioxidant profiles for controls and chronic
pancreatitics from Western and tropical popula-
tions are related to variations in culinary
practices at these locations. In South Africa this
is considered to be due to a poor dietary intake
of citrus fruit and in India, the degradation
of vitaminC and beta-carotene following pro-
longed frying of vegetables at high temperatures
may be responsible.
ENHANCED FREE RADICAL PRODUCTION
IN CHRONIC PANCREATITIS
The evidence that free radical production is
increased in patients with chronic pancreatitis is
derived from the observations that pancreatitics
have induction of the hepatic and pancreatic
mono-oxygenases and that their bile contains
high levels of free radical oxidation products.
The cytochrome P450 system of mono-oxyge-
nases are intimately involved in the metabolism
of lipophilic substrates such as hydrocarbons
[25]. The enzymes generate oxygen-free radicals
from molecular oxygen and use them to meta-
bolise their substrates by controlled release of
superoxide, and its dismutation product hydro-
gen peroxide. The hydrogen peroxide in turn
initiates a low grade peroxidation of membrane
lipids which appears to be an essential physio-
logical process. Upon exposure to exogenous
agents, the activities of cytochromes P450 in-
crease as part of a protective mechanism. This
defence mechanism can be detrimental if anti-
oxidant stores and depleted, and if agents that
undergo P450 metabolism (e.g., hydrocarbons)
are given concomitantly. This is exemplified by
animal experiments showing that following the
induction of the cytochromes P450 by alcohol,
the hepatotoxicity of hydrocarbons is accentu-
ated [26]. Further, a case-control study [27] of
patients with chronic pancreatitis has shown212 D.J. BOWREY et al.
that they have increased exposure to hydrocar-
bons, in particular diesel exhaust fumes com-
pared to controls. These environmental chemicals
would act in a manner similar to alcohol and
induce cytochromes P450.
Several studies have shown that the cyto-
chrome P450 enzyme system is induced in
patients suffering from chronic pancreatitis
[28-31]. Foster et al. [28] employed immunohis-
tochemistry using antibodies raised against four
phase I enzymes (metabolism) and one phase II
enzyme (conjugation) and compared the stain-
ing patterns in pancreatic and hepatic biopsies
from patients with chronic pancreatitis (n=6)
and pancreatic cancer (n=10) with a control
population of organ donors (n 7). Both hepatic
and pancreatic biopsy specimens from patients
with chronic pancreatitis and pancreatic carci-
noma showed enhanced staining for cytochrome
P450 compared to the staining pattern observed
in the control biopsies. Of note was the observa-
tion of cytochrome P450 induction in the islets of
Langerhans. The authors commented that this
may indicate a role in the development of type II
diabetes mellitus in this group of patients.
Inference of cytochrome P450 enzyme family
induction is derived from theophylline clearance
studies in patients with chronic pancreatitis.
Acheson et al. [29] studied 71 patients with
chronic pancreatitis and found that the theo-
phylline clearance was significantly higher in
patients with idiopathic and alcohol-related
chronic pancreatitis compared to controls. Uden
etal. [30] compared patients with chronic pan-
creatitis to a group of epileptic patients taking
long-term anticonvulsants, known inducers of
the cytochrome P450 enzyme system and found
that pancreatitics had a similar level of enzyme
induction to anticonvulsant-treated patients.
Comparison of the composition of secretin-
simulated bile from patients with pancreatic
disease (chronic. pancreatitis [n 11], pancreatic
cancer [n 5], recurrent acute pancreatitis [n 1])
to controls revealed that patients with pancreatic
disease had higher levels of free radical oxida-
tion products [32]. Guyan et al. [33] compared
the levels of free radical oxidation products in 25
patients with pancreatitis (15 chronic, 10 acute)
and 25 controls. Patients with chronic pancrea-
titis had significantly greater bile concentration
of 9 cis, 11 trans-linoleic acid, conjugated dienes
and ultraviolet fluorescence products compared
to controls. Patients with acute pancreatitis had
significantly elevated excretions of 9 cis, 11 trans-
linoleic acid and conjugated dienes but not
ultraviolet fluorescence products compared to
controls. These observations suggest that the
degree of oxidative stress is greatest in patients
with chronic pancreatitis and intermediate in
patients with acute pancreatitis.
The phospholipid component of secretin-sti-
mulated bile is derived almost exclusively from
hepatic bile and not pancreatic juice [34]. The
occurrence of high levels of free radicals activity
in the bile ofpatients with pancreatitiswould lend
support to the hypothesis that biliary reflux into
the pancreatic duct is the cause of pancreatitis.
However, the failure of biliary diversion to
prevent episodes of pancreatitis contradicts this
theory [31]. Sandilands et al. [31] obtained liver
and pancreatic biopsies per-operatively from 4
patients with chronic pancreatitis managed by
biliary diversion and found that both tissues
demonstrated similar histological findings. The
liver biopsies showed accumulation of microve-
sicular fat and lipofuscin and the pancreatic
biopsies revealed accumulation ofmicrovesicular
fat. The pancreas and liver, with a common
embryological origin from the endoderm of the
duodenum [35] react in a similar fashion to
oxidative stress. The liver, with its greater con-
jugation enzyme potential is less susceptible to
free radical injury than the pancreas.
SELENIUM REPLACEMENT THERAPY
IN CHRONIC PANCREATITIS
The first evidence suggesting a beneficial role for
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from Braganza et al., in 1987 [36]. The patient, a
61 year old female who suffered from recurrent
acute pancreatitis over a period of two years
experienced no further episodes at a follow-up
time of two years following treatment with
selenium (200tg), vitamins A, C and E. Sub-
sequent case reports from the same unit afforded
further evidence about the therapeutic value of
antioxidants in the treatment of chronic calcific
pancretatitis in a 10 year old boy and idiopathic
chronic pancreatitis in 4 adult male patients
[31,37]. This work served as pilot studies for a
randomised controlled trial by Dr. Braganza’s
group. In this study [38], the value of antiox-
idant therapy was assessed in 20 patients (8
idiopathic chronic pancreatitis, 7 alcohol-related
chronic pancreatitis, 5 recurrent acute pancrea-
titis) entered into a 20 week double-blind
double-dummy cross-over trial. Antioxidant
supplementation comprised 600 tg organic sele-
nium, 9000 iu beta-carotene, 0.54g vitamin C,
270 iu vitamin E and 2 g methionine. Six patients
experienced an attack of pancreatitis whilst on
placebo, whilst none receiving active treatment
did. Further, pain scores assessed using visual
analogue scores were significantly improved
whilst patients received active treatment com-
pared to the baseline pain scores.
In an attempt to identify the active ingredient
in the global antioxidant therapy described in the
above study, Bilton et al. [39] studied the effects
of the active component of methionine, S-
adenosyl-methionine in 20 patients with chronic
pancreatitis in a placebo-controlled trial per-
formed over a period of 20 weeks. As this
treatment alone was ineffective, the investigators
studied the effect of co-administering selenium
and beta-carotene, with the S-adenosyl-methio-
nine. This treatment also proved ineffective and
the authors concluded that the global antioxidant
therapy was required to achieve a beneficial
therapeutic response in patients with chronic
pancreatitis. This should include S-adenosyl
methionine, selenium and vitamins A, C and E.
There is only anecdotal evidence [40] of the
potential reduction in morbidity and the finan-
cial savings of administering global antioxidant
therapy to all patients with chronic pancreatitis.
An audit at Manchester of 103 patients treated
with antioxidant therapy revealed that at a
follow-up of up to 9 years, 75 patients were
pain-free and that 27 patients had substantial
reductions in their pain. Only 7 patients
required surgery, pseudocyst drainage in 6
patients and cholecystectomy in one patient.
CONCLUSIONS
It is likely that there is a common aetiology to
chronic pancreatitis related to abnormal proces-
sing of oxygen free radical products generated
by a range of xenobiotics however, it is not
known how alcohol is related to this. There is
little doubt that patients with chronic pancrea-
titis have low levels of selenium compared with
non-pancreatitics however it is uncertain at
present whether this is the causal or merely an
effect of the disease process. It may be that
oxidative stress is triggered, in an individual of
antioxidant deficient status, by ischaemic da-
mage secondary to dilatation of the intrapan-
creatic ductal system [41]. It has recently been
demonstrated in a feline model that an ob-
structed ductal system within a fibrous pancreas
causes a "compartment syndrome". This leads
to a reduced pancreatic blood flow and ischae-
miac damage, which is turn may generate
further free radical species.
As China opens its doors to the West, the
results of large-scale population studies in
endemic regions will no doubt clarify the
relationship between selenium deficiency and
chronic pancreatitis.
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COMMENT ON "SELENIUM DEFICIENCY
AND CHRONIC PANCREATITIS: DISEASE
MECHANISM AN POTENTIAL
FOR THERAPY"
Although much has been done to improve our
understanding of the pathophysiology of
chronic pancreatitis, there is still no therapy that
counteracts the inflammatory process of the
disease. One reason for this lack of knowledge
is that one may assume that the etiology of
chronic pancreatis multifactorial; selenium defi-
ciency being one of these factors.
Most patients presenting with chronic pan-
creatitis in Europe, United States, and South
Africa will have alcohol-related disease, and
there are indications that this type of disease is
increasing [1]. Pain is the cardinal symptom in
chronic pancreatitis, and together with the usual
problem of contemporary alcoholism, is the
most difficult feature to treat [2]. For some
patients with these diseases the pain is so severe
that all walking hours are devoted to its control;
quality of life is very poor [3]. As we are dealing
with a devastating disease with unclear basic
pathophysiology all contributions to the knowl-
edge of etiology are welcome, especially if new
knowledge can be used therapeutically.
It is possibly correct to state that most patients
with chronic pancreatitis have a deficiency of
selenium. However, the patients with chronic
pancreatitis are also smokers that eat little fruit
and vegetables, and consume large quantities of
alcohol. This can not be disregarded as alcohol
per se is correlated to smoking [4,5]. Also the
correlation between an unhealthy diet and
alcoholism is strong. These types of confounding
factors must be taken into account when
discussing potential causal relationships be-
tween the dietary influence on pathophysiology.
In alcoholic chronic pancreatitis, cessation of
alcohol abuse has an impact on the natural
course of the disease. Although impairment of
pancreatic function progresses after cessetion in
most patients, the progress is slower and less
severe [6,7]. In about 50 percent of patients,
cessation of alcohol abuse is accompanied by a
decreased severity of pain [7-9]. Patients with
early onset idiopathic chronic pancreatitis usual-
ly live longer through a long period of severe
pain but slowly develop morphological and
functional pancreatic damage, whereas patients
with late onset idiopathic chronic pancreatitis
have a mild and painless course [10,11]. This
must be explained-or at least discussed-in the
light of the selenium state presented by Bowrey
et al.
The mechanisms underlying the generation
and perpetuation of the pain in chronic pan-
creatitis is unsufficiently known. Bockman et al.
[12] have shown an increase both in the number
and diameter of pancreatic nerve fibers in
tissues from patients with chronic pancreatitis
compared with the normal pancreas and B6chler
et al. [13] found that the pattern of intrinsic and
possibly extrinsic innervation of the pancreas is
changed in chronic pancreatitis. This leads to a
differential expression of neuropeptides such as
substance P and vasoactive intestinal peptide in216 D.J. BOWREY et al.
the chronically inflamed pancreas. Moreover,
Nelson et al. [14] have reported that changes in
levels of methionine-enkephalin correlates with
pain, and recently it was found that immune cell
infiltration and growth-associated protein 43
expression correlate with pain in chronic pan-
creatitis [15]. In the future, these facts must be
taken into account not only when tayloring the
treatment for the patient with chronic pancrea-
titis but also when discussing etiology. So far the
connexions between the dietary selenium defi-
ciency and the nerve injuries have not been well
elucidated, which means that even though the
concept of oxidative stress seems well founded,
much more remains to be done in this research
field.
ke Andr6n-Sandberg
Department of Surgery,
Haukeland University Hospital,
Bergen, Norway
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